PG
IBB icon

PEAK6 Group’s iShares Biotechnology ETF IBB Stock Holding History

PEAK6 Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$6.85M Buy
62,400
+15,000
+32% +$1.6M 0.03% 621
2018
Q1 		$5.06M Sell
47,400
-50,700
-52% -$5.62M 0.02% 795
2017
Q4 		$10.5M Hold
98,100
– – 0.05% 444
2017
Q3 		$10.9M Sell
98,100
-30,300
-24% -$3.24M 0.06% 374
2017
Q2 		$13.3M Buy
+128,400
New +$12.6M 0.08% 278
2017
Q1 		– Sell
-7,500
Closed -$663K – 4593
2016
Q4 		$663K Sell
7,500
-34,500
-82% -$3.14M ﹤0.01% 2242
2016
Q3 		$4.05M Buy
42,000
+1,200
+3% +$114K 0.03% 811
2016
Q2 		$3.5M Sell
40,800
-14,700
-26% -$1.32M 0.03% 870
2016
Q1 		$4.83M Sell
55,500
-237,300
-81% -$21.2M 0.04% 640
2015
Q4 		$33M Buy
292,800
+146,700
+100% +$15.9M 0.22% 60
2015
Q3 		$14.8M Sell
146,100
-124,200
-46% -$14.9M 0.08% 313
2015
Q2 		$33.2M Buy
270,300
+174,900
+183% +$20.9M 0.2% 73
2015
Q1 		$10.9M Buy
95,400
+28,500
+43% +$3.14M 0.08% 289
2014
Q4 		$6.76M Buy
+66,900
New +$6.5M 0.05% 483
2014
Q3 		– Sell
-55,500
Closed -$4.75M – 4880
2014
Q2 		$4.75M Sell
55,500
-91,200
-62% -$7.19M 0.05% 548
2014
Q1 		$11.6M Buy
146,700
+26,700
+22% +$2.22M 0.1% 227
2013
Q4 		$9.08M Buy
+120,000
New +$8.51M 0.06% 376
2013
Q3 		– Sell
-36,600
Closed -$2.12K – 5271
2013
Q2 		$2.12K Buy
+36,600
New +$2.12M 0.01% 1473

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

PEAK6 Group's IBB Position: Q2 2018 in Review

PEAK6 Group opened a new position in iShares Biotechnology ETF (IBB) in Q2 2018: 34,807 shares worth $3.82M. The stake represents 0.02% of the portfolio and ranks #923 among its holdings. This is a return to the name: PEAK6 Group previously reported a position in IBB as recently as Q4 2017.

PEAK6 Group first reported a position in IBB in Q2 2014 and has held it in 14 quarters since. The position peaked at $13.7M in Q4 2017. 609 funds tracked by Wall St. Rank hold IBB as of Q2 2018.

  • PEAK6 Group held 34,807 shares of iShares Biotechnology ETF worth $3.82M as of Q2 2018.
  • iShares Biotechnology ETF was a new PEAK6 Group position in Q2 2018.
  • iShares Biotechnology ETF made up 0.02% of PEAK6 Group's portfolio in Q2 2018, its #923 holding.
  • PEAK6 Group first reported a position in iShares Biotechnology ETF in Q2 2014 and has held it in 14 quarters since.
  • PEAK6 Group's iShares Biotechnology ETF position peaked at $13.7M in Q4 2017.
  • 609 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.